Product Information
ARIPIPRAZOLE 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1743 per EA under NDC 65862066530. Its NADAC has been published 568 times since Nov 18, 2015.
FDA first approved this application on Oct 8, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862066530
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203908FDA Approved
10/8/2015
TE Code
AB
On Market Since
10/8/2015
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 20 MG TABLET has been published 568 times since Nov 18, 2015, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1743 per EA |
|---|---|
| All-time high | $17.6073 (Dec 16, 2015) |
| All-time low | $0.1653 (Jul 22, 2026) |
| 52-week high | $0.1834 |
| 52-week low | $0.1653 |
| Median price | $0.2616 |
| Average price | $1.3038 |
| Largest weekly change | -30.7% (Jul 22, 2020) |
| Weeks tracked | 568 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1743 per EA (NDC 65862066530), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 20 MG TABLET has declined 99.0%. It has been tracked across 568 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 20 MG TABLET?
Since Nov 18, 2015, the NADAC for ARIPIPRAZOLE 20 MG TABLET has ranged from a low of $0.1653 (Jul 22, 2026) to a high of $17.6073 (Dec 16, 2015), with a median of $0.2616 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 20 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 20 MG TABLET?
ARIPIPRAZOLE 20 MG TABLET (NDC 65862066530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.